Acute kernicterus in a neonate with O/B blood group incompatibility and a mutation in SLC4A1

Pediatrics

Volumn 132, Issue 2, 2013, Pages

  Christensen, Robert D ^a   Yaish, Hassan M ^b   Nussenzveig, Roberto H ^c,d   Reading, N Scott ^c,d   Agarwal, Archana M ^c,d   Eggert, Larry D ^a   Prchal, Josef T ^c,d,e  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b Division of Hematology/Oncology   (United States)

^c Department of Pathology ^*  (United States)

^d ARUP LABORATORIES   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

ABO; Hemolysis; Hereditary spherocytosis; Jaundice; Kernicterus; Neonate

Indexed keywords

BILIRUBIN;

ACUTE KERNICTERUS; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP OB INCOMPATIBILITY; CASE REPORT; ERYTHROCYTE DISORDER; EXCHANGE BLOOD TRANSFUSION; FEMALE; FOLLOW UP; GENE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HOME CARE; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; KERNICTERUS; MEDICAL DEVICE; NEWBORN; PHOTOTHERAPY; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SLC4A1 GENE;

EID: 84882252406     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3799     Document Type: Article

References (20)

1. Bhutani VK, Johnson L. Synopsis report from the pilot USA Kernicterus Registry. J Perinatol. 2009;29(suppl 1):S4-S7
2. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol. 2009;29(suppl 1):S25-S45
3. Christensen RD, Lambert DK, Henry E, et al. Unexplained extreme hyperbilirubinemia among neonates in a multihospital healthcare system. Blood Cells Mol Dis. 2013;50(2): 105-109
4. Christensen RD, Henry E, Jopling J, Wiedmeier SE. The CBC: reference ranges for neonates. Semin Perinatol. 2009;33(1):3-11
5. King MJ, Telfer P, MacKinnon H, et al. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry B Clin Cytom. 2008;74(4):244-250
6. Kar R, Mishra P, Pati HP. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol. 2010;32(1 pt 2):8-16
7. Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372 (9647):1411-1426
8. Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics. 2006;118(1):276-279
9. Watchko JF, Lin Z, Clark RH, Kelleher AS, Walker MW, Spitzer AR; Pediatrix Hyperbilirubinemia Study Group. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics. 2009; 124(5). Available at: www.pediatrics.org/cgi/content/full/124/5/e868
10. Watchko JF, Lin Z. Exploring the genetic architecture of neonatal hyperbilirubinemia. Semin Fetal Neonatal Med. 2010;15(3): 169-175
11. Kaplan M, Muraca MM, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110(4). Available at: www.pediatrics.org/cgi/content/ full/110/4/e47
12. Stevenson DK, Vreman HJ, Wong RJ. Bilirubin production and the risk of bilirubin neurotoxicity. Semin Perinatol. 2011;35(3): 121-126
13. Berardi A, Lugli L, Ferrari F, et al. Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol Neonate. 2006;90(4):243-246
14. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA. 1997;94(22):12128-12132
15. Kaplan M, Hammerman C, Vreman HJ, Stevenson DK, Beutler E. Acute hemolysis and severe neonatal hyperbilirubinemia in glucose-6-phosphate dehydrogenasedeficient heterozygotes. J Pediatr. 2001; 139(1):137-140
16. Prchal JT, Guan Y, Jarolim P, Palek J, Showe L, Bertoli L. Hereditary spherocytosis in a large family is linked with the band 3 gene and not with alpha-spectrin, betaspectrin or ankyrin. Blood. 1991;78(suppl):81a
17. Jarolim P, Murray JL, Rubin HL, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 1996;88(11):4366-4374
18. Maisels MJ. Neonatal hyperbilirubinemia and kernicterus -not gone but sometimes forgotten. Early Hum Dev. 2009;85(11):727-732
19. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316
20. Stevenson DK, Vreman HJ, Oh W, et al. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem. 1994;40(10):1934-1939